Finance

Lists
543635:BOM
Piramal Pharma Ltd (Mumbai)
₹193,95
-1,15%
(-2,25) 1D
14 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543635...
Open
₹195,60
High
₹196,60
Low
₹192,60
Mkt. cap
256,14 mjd
Avg. vol.
393,68 k
Volume
108,45 k
52-wk high
₹231,85
52-wk low
₹132,50
EPS
-₹2,37
No. of employees
7 k
Open
₹195,60
High
₹196,60
Low
₹192,60
Mkt. cap
256,14 mjd
Avg. vol.
393,68 k
Volume
108,45 k
52-wk high
₹231,85
52-wk low
₹132,50
EPS
-₹2,37
No. of employees
7 k
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
16 minute gelede
FILE PHOTO: SK Hynix at the Nasdaq market in New York
The Globe and Mail
The Globe and Mail
·
33 minute gelede
U.S. Analyst Updates: October 14th, 2026
About Piramal Pharma Ltd (Mumbai)
CEOPeter DeYoung
Employees7,12 k
Founded2020
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
20,44 mjd
21,40 mjd
27,52 mjd
22,70 mjd
Cost of goods sold
7,02 mjd
7,86 mjd
13,95 mjd
8,52 mjd
Cost of revenue
7,02 mjd
7,86 mjd
13,95 mjd
8,52 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,11 mjd
6,00 mjd
8,19 mjd
6,76 mjd
Operating expense
13,85 mjd
13,71 mjd
11,09 mjd
14,46 mjd
Total operating expenses
20,88 mjd
21,57 mjd
25,04 mjd
22,98 mjd
Operating income
-441,50 m
-170,10 m
2,47 mjd
-283,50 m
Other non operating income
656,00 m
432,40 m
-977,90 m
894,10 m
EBT including unusual items
-461,80 m
-938,60 m
430,00 m
-74,60 m
EBT excluding unusual items
-461,80 m
-527,50 m
1,40 mjd
-74,60 m
Income tax expense
530,40 m
423,30 m
518,30 m
619,30 m
Effective tax rate
-114,85%
-45,10%
120,53%
-830,16%
Other operating expenses
5,71 mjd
5,58 mjd
723,30 m
5,47 mjd
Net income
-992,20 m
-1,36 mjd
-88,30 m
-693,90 m
Net profit margin
-4,85%
-6,36%
-0,32%
-3,06%
Earnings per share
-0,75
-0,72
1,32
-0,52
Interest and investment income
-
-
70,70 m
-
Interest expense
-824,20 m
-892,40 m
-805,40 m
-880,80 m
Net interest expenses
-824,20 m
-892,40 m
-734,70 m
-880,80 m
Depreciation and amortization charges
2,03 mjd
2,13 mjd
2,18 mjd
2,24 mjd
EBITDA
1,45 mjd
1,68 mjd
4,32 mjd
1,57 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme